SecBot SecBot
8-K ·Filed May 7, 2026

STE

STERIS plc
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001193125-26-212159
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

This is a routine board refresh with no financial or operational implications. No trading action warranted. Monitor for any future strategic shifts that Boulud's diagnostics background might influence, but no near-term catalyst.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$207.24
T+0 close · May 7, 2026 · via day close
Latest settled
+12.26%
T+60 · $232.64
Vs SPY
+9.54%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 8 $207.24entry
  2. T+1 · 6mo ago −2.93%α −3.17% · $201.16
  3. T+5 · 6mo ago +4.22%α +2.75% · $215.98
  4. T+20 · 5mo ago +2.47%α +2.44% · $212.35
  5. T+60 · 3mo ago +12.26%α +9.54% · $232.64

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

STERIS filed an 8-K reporting the retirement of director Richard C. Breeden (not standing for reelection after 18 years) and the appointment of Pierre Boulud, CEO of bioMérieux, to the board. This is a routine board refresh with no material financial impact, no financial data, guidance, or operational changes were disclosed.

Key Facts

  • Director Richard C. Breeden will not stand for reelection at the 2026 Annual General Meeting; his retirement is not due to any disagreement with the company.
  • Board size increased from 9 to 10 members; Pierre Boulud appointed effective May 5, 2026.
  • Pierre Boulud is CEO of bioMérieux (in vitro diagnostics) and previously held senior roles at Ipsen and Boston Consulting Group.
  • Boulud will receive a prorated fee of $76,989 in career restricted stock units for the remainder of the board's 2025-26 term.

Financial Impact

No material financial impact. Director compensation of $76,989 in restricted stock units is immaterial for a $21B market cap company.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
67% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-212159
Document: d27562dex991.htm0001193125-26-212159
Document: 0001193125-26-212159-index-headers.html0001193125-26-212159
Document: 0001193125-26-212159-index.html0001193125-26-212159
Document: 0001193125-26-212159.txt0001193125-26-212159

Track record

21 reports on STE

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +17.96% at T+20 after the Oct 13, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $264.32 Now $264.32 +0.00% settles Nov 23
  2. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $264.32 Now $264.32 +0.00% settles Nov 20
  3. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $264.32 Now $264.32 +0.00% settles Nov 20
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $253.44 Now $264.32 +4.29% settles Nov 19
  5. Nov 10, 20266d ago 144 Neutral 2/10 Entry $256.27 Now $264.32 +3.14% settles Nov 18
  6. Nov 4, 202612d ago 8-K Neutral 4/10 Entry $254.12 to $253.44 Now $264.32 +4.01% ▼ −0.27% −3.56% vs SPY
  7. Nov 4, 202612d ago 8-K Bullish 6/10 No price data
  8. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $254.12 to $253.44 Now $264.32 +4.01% ▼ −0.27% −3.56% vs SPY
  9. Oct 28, 202619d ago Press Release Neutral 2/10 Entry $232.14 to $254.12 Now $264.32 +13.86% ▲ +9.47% +14.19% vs SPY
  10. Oct 20, 202627d ago Press Release Neutral 1/10 Entry $221.48 to $228.49 Now $264.32 +19.34% ▲ +3.17% +3.61% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens Wed (13h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 7, 2026